Download original image
Fig. 4. CAP2 induces EMT in liver cancer cells via ERK activation.
(A and B) SNU423-Vector, SNU423-CAP2, Huh7-Vector, and Huh7-CAP2 cells are subjected to Western blotting with the indicated antibodies. (C) SNU423-Vector and SNU423-CAP2 cells are treated for 24 h with or without the ERK inhibitor U0126 (20 μM), followed by Western blotting with the indicated antibodies. CAP2 is indicated by asterisks (*).
© Mol. Cells